Learn more about whether Sanofi or Zoetis Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The three drug discovery deals are with Convelo Therapeutics in neurological disorders such as multiple sclerosis, Sosei Heptares for G-protein-coupled receptor-targeting compounds, and Skyhawk ...

It's not the first partnership for Biogen in the RNA splicing area. In 2019, the biopharma teamed up with Skyhawk Therapeutics to try to find small-molecule drugs that could modulate RNA splicing ...

Despite the competitive threat posed by Eli Lilly’s acquisition of Scorpion Therapeutics’ STX-478, which has shown promising efficacy in several cancer types, Relay Therapeutics’ RLY-2608 ...

A Quick Take On Odyssey Therapeutics, Inc. Odyssey Therapeutics, Inc. (ODTX) has filed to raise $100 million in an IPO of its ordinary shares, according to SEC S-1 registration information.

Perspective Therapeutics reports no dose-limiting toxicities or severe adverse events in Phase 1/2a trial of [212Pb]VMT-α-NET. Anti-tumor activity observed: 1 confirmed response (17 weeks), 2 ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...

Dyne Therapeutics Inc. 4.43% $1.38B ...

After hours: January 28 at 4:01:40 PM EST Loading Chart for SLNO ...